Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36234887)
Watch
English
Epidermal growth factor receptor pathway inhibitors.
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Epidermal growth factor receptor pathway inhibitors
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
author
Javier Cortes
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
author name string
Jose Baselga
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
publication date
1 January 2005
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
published in
Cancer chemotherapy and biological response modifiers
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
volume
22
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
page(s)
205-223
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
cites work
Untangling the ErbB signalling network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The ErbB signaling network: receptor heterodimerization in development and cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cell signaling by receptor tyrosine kinases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGF mutant receptor vIII as a molecular target in cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Signal transduction through MAP kinase cascades
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncogenic kinase signalling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The phosphatidylinositol 3-Kinase AKT pathway in human cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor-related peptides and their receptors in human malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stat3 as an oncogene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of gefitinib in recurrent glioblastoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combinatorial chemoprevention of intestinal neoplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A gene-expression signature as a predictor of survival in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proteomic patterns of tumour subsets in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The EGF receptor family as targets for cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0921-4410(04)22009-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
PubMed publication ID
16110613
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110613
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110613%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit